Your browser doesn't support javascript.
loading
A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.
Lasham, Annette; Mehta, Sunali Y; Fitzgerald, Sandra J; Woolley, Adele G; Hearn, James I; Hurley, Daniel G; Ruza, Igor; Algie, Michael; Shelling, Andrew N; Braithwaite, Antony W; Print, Cristin G.
Afiliação
  • Lasham A; Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Mehta SY; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Fitzgerald SJ; Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Woolley AG; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Hearn JI; Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Hurley DG; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Ruza I; Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Algie M; Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Shelling AN; Bioinformatics Institute, University of Auckland, Auckland, New Zealand.
  • Braithwaite AW; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Print CG; Systems Biology Laboratory, Melbourne School of Engineering, University of Melbourne, Melbourne, Australia.
Int J Cancer ; 139(5): 1157-70, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27072400
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Proteína 1 de Ligação a Y-Box / Proteína 1 de Resposta de Crescimento Precoce / Neoplasias de Mama Triplo Negativas / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Nova Zelândia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Proteína 1 de Ligação a Y-Box / Proteína 1 de Resposta de Crescimento Precoce / Neoplasias de Mama Triplo Negativas / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Nova Zelândia País de publicação: Estados Unidos